Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1517169

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1517169

Global colorectal cancer therapeutics market 2024-2028

PUBLISHED:
PAGES: 146 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Global Colorectal CancerTherapeutics Market 2024-2028

The colorectal cancer therapeutics market is forecasted to grow by USD 2001.8 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the colorectal cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing geriatric population, rising occurrence of colorectal cancer, and introduction of combination therapeutics.

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20244.23%
CAGR4.5%
Incremental Value$2001.8mn

Technavio's colorectal cancertherapeutics market is segmented as below:

By Type

  • Targeted therapy
  • Immunotherapy
  • Chemotherapy

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the development of small molecule kinase inhibitors as one of the prime reasons driving the colorectal cancer therapeutics market growth during the next few years. Also, advent of gene therapy and personalized therapeutics will lead to sizable demand in the market.

The report on the colorectal cancer therapeutics market covers the following areas:

  • Colorectal cancer therapeutics market sizing
  • Colorectal cancer therapeutics market forecast
  • Colorectal cancer therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading colorectal cancer therapeutics market vendors that include Accord Healthcare Ltd., Amgen Inc., Amneal Pharmaceuticals Inc., Bayer AG, Biocon Ltd., Bristol Myers Squibb Co., CK Hutchison Holdings Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Hetero Drugs Ltd., Hikma Pharmaceuticals PLC, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the colorectal cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR72411

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Colorectal Cancer Therapeutics Market 2018 - 2022
    • Historic Market Size - Data Table on Global Colorectal Cancer Therapeutics Market 2018 - 2022 ($ million)
  • 4.2 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.3 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.4 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type

  • 6.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 6.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 6.3 Targeted therapy - Market size and forecast 2023-2028
    • Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
  • 6.4 Immunotherapy - Market size and forecast 2023-2028
    • Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
  • 6.5 Chemotherapy - Market size and forecast 2023-2028
    • Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

7 Customer Landscape

  • 7.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

  • 8.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 8.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 8.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 8.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 8.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 8.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 8.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 8.8 Germany - Market size and forecast 2023-2028
    • Chart on Germany - Market size and forecast 2023-2028 ($ million)
    • Data Table on Germany - Market size and forecast 2023-2028 ($ million)
    • Chart on Germany - Year-over-year growth 2023-2028 (%)
    • Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • 8.9 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 8.10 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 8.11 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 8.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

  • 9.1 Market drivers
  • 9.2 Market challenges
  • 9.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 9.4 Market opportunities/restraints

10 Competitive Landscape

  • 10.1 Overview
  • 10.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 10.3 Landscape disruption
    • Overview on factors of disruption
  • 10.4 Industry risks
    • Impact of key risks on business

11 Competitive Analysis

  • 11.1 Companies profiled
    • Companies covered
  • 11.2 Market positioning of companies
    • Matrix on companies position and classification
  • 11.3 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
  • 11.4 Bayer AG
    • Bayer AG - Overview
    • Bayer AG - Business segments
    • Bayer AG - Key news
    • Bayer AG - Key offerings
    • Bayer AG - Segment focus
  • 11.5 Biocon Ltd.
    • Biocon Ltd. - Overview
    • Biocon Ltd. - Business segments
    • Biocon Ltd. - Key offerings
    • Biocon Ltd. - Segment focus
  • 11.6 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
  • 11.7 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key news
    • Eli Lilly and Co. - Key offerings
  • 11.8 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 11.9 Fresenius SE and Co. KGaA
    • Fresenius SE and Co. KGaA - Overview
    • Fresenius SE and Co. KGaA - Business segments
    • Fresenius SE and Co. KGaA - Key news
    • Fresenius SE and Co. KGaA - Key offerings
    • Fresenius SE and Co. KGaA - Segment focus
  • 11.10 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
  • 11.11 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
  • 11.12 Viatris Inc.
    • Viatris Inc. - Overview
    • Viatris Inc. - Business segments
    • Viatris Inc. - Key news
    • Viatris Inc. - Key offerings
    • Viatris Inc. - Segment focus

12 Appendix

  • 12.1 Scope of the report
  • 12.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 12.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 12.4 Research methodology
    • Research methodology
  • 12.5 Data procurement
    • Information sources
  • 12.6 Data validation
    • Data validation
  • 12.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 12.8 Data synthesis
    • Data synthesis
  • 12.9 360 degree market analysis
    • 360 degree market analysis
  • 12.10 List of abbreviations
    • List of abbreviations
Product Code: IRTNTR72411

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Company Market Positioning
  • Exhibits9: Parent Market
  • Exhibits10: Data Table on - Parent Market
  • Exhibits11: Market characteristics analysis
  • Exhibits12: Value Chain Analysis
  • Exhibits13: Offerings of companies included in the market definition
  • Exhibits14: Market segments
  • Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Historic Market Size - Data Table on Global Colorectal Cancer Therapeutics Market 2018 - 2022 ($ million)
  • Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits23: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits29: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits30: Chart on Type - Market share 2023-2028 (%)
  • Exhibits31: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits32: Chart on Comparison by Type
  • Exhibits33: Data Table on Comparison by Type
  • Exhibits34: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits35: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits36: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits37: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits38: Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits39: Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits40: Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits41: Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits42: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits43: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits44: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits45: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits46: Market opportunity by Type ($ million)
  • Exhibits47: Data Table on Market opportunity by Type ($ million)
  • Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits51: Chart on Geographic comparison
  • Exhibits52: Data Table on Geographic comparison
  • Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Market opportunity By Geographical Landscape ($ million)
  • Exhibits90: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits91: Impact of drivers and challenges in 2023 and 2028
  • Exhibits92: Overview on criticality of inputs and factors of differentiation
  • Exhibits93: Overview on factors of disruption
  • Exhibits94: Impact of key risks on business
  • Exhibits95: Companies covered
  • Exhibits96: Matrix on companies position and classification
  • Exhibits97: Amgen Inc. - Overview
  • Exhibits98: Amgen Inc. - Product / Service
  • Exhibits99: Amgen Inc. - Key news
  • Exhibits100: Amgen Inc. - Key offerings
  • Exhibits101: Bayer AG - Overview
  • Exhibits102: Bayer AG - Business segments
  • Exhibits103: Bayer AG - Key news
  • Exhibits104: Bayer AG - Key offerings
  • Exhibits105: Bayer AG - Segment focus
  • Exhibits106: Biocon Ltd. - Overview
  • Exhibits107: Biocon Ltd. - Business segments
  • Exhibits108: Biocon Ltd. - Key offerings
  • Exhibits109: Biocon Ltd. - Segment focus
  • Exhibits110: Bristol Myers Squibb Co. - Overview
  • Exhibits111: Bristol Myers Squibb Co. - Product / Service
  • Exhibits112: Bristol Myers Squibb Co. - Key news
  • Exhibits113: Bristol Myers Squibb Co. - Key offerings
  • Exhibits114: Eli Lilly and Co. - Overview
  • Exhibits115: Eli Lilly and Co. - Product / Service
  • Exhibits116: Eli Lilly and Co. - Key news
  • Exhibits117: Eli Lilly and Co. - Key offerings
  • Exhibits118: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits119: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits120: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits121: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits122: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits123: Fresenius SE and Co. KGaA - Overview
  • Exhibits124: Fresenius SE and Co. KGaA - Business segments
  • Exhibits125: Fresenius SE and Co. KGaA - Key news
  • Exhibits126: Fresenius SE and Co. KGaA - Key offerings
  • Exhibits127: Fresenius SE and Co. KGaA - Segment focus
  • Exhibits128: Merck and Co. Inc. - Overview
  • Exhibits129: Merck and Co. Inc. - Business segments
  • Exhibits130: Merck and Co. Inc. - Key news
  • Exhibits131: Merck and Co. Inc. - Key offerings
  • Exhibits132: Merck and Co. Inc. - Segment focus
  • Exhibits133: Sanofi SA - Overview
  • Exhibits134: Sanofi SA - Business segments
  • Exhibits135: Sanofi SA - Key news
  • Exhibits136: Sanofi SA - Key offerings
  • Exhibits137: Sanofi SA - Segment focus
  • Exhibits138: Viatris Inc. - Overview
  • Exhibits139: Viatris Inc. - Business segments
  • Exhibits140: Viatris Inc. - Key news
  • Exhibits141: Viatris Inc. - Key offerings
  • Exhibits142: Viatris Inc. - Segment focus
  • Exhibits143: Inclusions checklist
  • Exhibits144: Exclusions checklist
  • Exhibits145: Currency conversion rates for US$
  • Exhibits146: Research methodology
  • Exhibits147: Information sources
  • Exhibits148: Data validation
  • Exhibits149: Validation techniques employed for market sizing
  • Exhibits150: Data synthesis
  • Exhibits151: 360 degree market analysis
  • Exhibits152: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!